Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Genetic Predictors of the Development and Recurrence of Graves’ Disease
source: Physiological Research / Academia Scientiarum Bohemoslovaca
authors: Vejrazkova D, Vcelak J, Vaclavikova E, Vankova M, Zajickova K, Duskova M, Vrbikova J, Bendlova Bsummary/abstract:
Graves’ disease affects approximately 3 % of women and 0.5 % of men. The first-choice therapy is based on the administration of thyrostatic drugs. However, approximately half of patients relapse within two years of discontinuation. These patients must then decide whether to re-initiate thyrostatics, which may have serious side effects, or to undergo surgery or radioiodine treatment.
Familial forms of Graves’ disease indicate a significant genetic component, with twin studies demonstrating a contribution of genetic factors up to 70-80 %. The autoimmune nature of the disease involves the human leukocyte antigen (HLA) complex, which has a decisive impact on each individual’s immune response. Within HLA, some variants of the DRB1, DQA1 and DQB1 genes appear to be possible predictors of the development and recurrence of Graves’ disease.
Outside the HLA region, many variants of immunocompetent genes have also been identified as potential Graves’ disease predictors. Apart from the immune system, some thyroid-specific genes have been described in relation to the disease. Here, we present current knowledge regarding the genetic components involved in the development and recurrence of Graves’ disease. Further, we present original pilot results from a cohort of Czech Graves’ disease patients regarding the HLA variants.organization: Institute of Endocrinology, Czech Republic
read more full text
New York Walk & Public ForumWe walk to raise awareness, and to honor...
Los Angeles WalkWe walk to raise awareness, and to honor...
The Natural History of Subclinical Hyperthyroidism in Graves’ Disease: The Rule of Thirds.Background: There is little information...
Pittsburgh Walk & Public ForumWe walk to raise awareness, and to honor...
Triiodothyronine-Predominant Graves’ Disease in Childhood: Detection and Therapeutic ImplicationsObjective: To assess in a pediatric pop...
Hepatic Dysfunction Related to Thyrotropin Receptor Antibody in Patients With Graves’ DiseaseBackground: Hepatic dysfunction is a co...
Thyroglobulin Autoantibodies are Associated With Refractoriness to Antithyroid Drug Treatment for Graves’ Dise...Objective: The recurrence rate associat...
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.